Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results
Provided By GlobeNewswire
Last update: Aug 13, 2024
NEW YORK, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to improving the lives of people affected by rare epilepsies and brain conditions, today reported business updates and financial results for the second quarter ended June 30, 2024.
Read more at globenewswire.com
